The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C

de Gregorio, Amelie; Janni, Wolfgang; Friedl, Thomas W. P.; Nitz, Ulrike; Rack, Brigitte; Schneeweiss, Andreas; Kates, Ronald; Fehm, Tanja; Kreipe, Hans; Christgen, Matthias; Kuemmel, Sherko; Trapp, Elisabeth; Wuerstlein, Rachel; Haertkopf, Andreas; Clemens, Michael; Reimer, Toralf; Haeberle, Lothar; Fasching, Peter A.; Gluz, Oleg; Harbeck, Nadia

dc.contributor.author	Hartkopf, Andreas
dc.date.accessioned	2023-01-24T11:38:03Z
dc.date.available	2023-01-24T11:38:03Z
dc.date.issued	2022
dc.identifier.issn	0007-0920
dc.identifier.uri	http://hdl.handle.net/10900/135602
dc.language.iso	en	de_DE
dc.publisher	Springernature	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41416-021-01690-6	de_DE
dc.subject.ddc	610	de_DE
dc.title	The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_01905
utue.publikation.seiten	1715-1724	de_DE
utue.personen.roh	de Gregorio, Amelie
utue.personen.roh	Janni, Wolfgang
utue.personen.roh	Friedl, Thomas W. P.
utue.personen.roh	Nitz, Ulrike
utue.personen.roh	Rack, Brigitte
utue.personen.roh	Schneeweiss, Andreas
utue.personen.roh	Kates, Ronald
utue.personen.roh	Fehm, Tanja
utue.personen.roh	Kreipe, Hans
utue.personen.roh	Christgen, Matthias
utue.personen.roh	Kuemmel, Sherko
utue.personen.roh	Trapp, Elisabeth
utue.personen.roh	Wuerstlein, Rachel
utue.personen.roh	Haertkopf, Andreas
utue.personen.roh	Clemens, Michael
utue.personen.roh	Reimer, Toralf
utue.personen.roh	Haeberle, Lothar
utue.personen.roh	Fasching, Peter A.
utue.personen.roh	Gluz, Oleg
utue.personen.roh	Harbeck, Nadia
dcterms.isPartOf.ZSTitelID	British Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	126	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE